Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 * | 90.48M 112M | Sales 2024 * | 130M 161M | Capitalization | 205M 254M |
---|---|---|---|---|---|
Net income 2023 * | -89M -110M | Net income 2024 * | -38M -47.11M | EV / Sales 2023 * | 1.72 x |
Net cash position 2023 * | 49.23M 61.03M | Net cash position 2024 * | 15.51M 19.22M | EV / Sales 2024 * | 1.46 x |
P/E ratio 2023 * |
-2.25
x | P/E ratio 2024 * |
-5.33
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |